These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 643900)

  • 1. Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
    Longo VG; Loizzo A
    Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
    Loew DM; Jaton AL; Vigouret JM
    Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
    [No Abstract]   [Full Text] [Related]  

  • 5. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dihydroergotoxine, bromocriptine, and ergotamine on penile erection in Wistar rats.
    Radosavljevic M; Pajovic B; Radunovic M; Radojevic N; Bjelogrlic B
    J Androl; 2012; 33(5):866-71. PubMed ID: 22441761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology of synthetic ergot derivatives in man.
    Lemberger L; Crabtree RE
    Adv Biochem Psychopharmacol; 1980; 23():117-24. PubMed ID: 6104905
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
    Anlezark G; Meldrum B
    Psychopharmacology (Berl); 1978 Apr; 57(1):57-62. PubMed ID: 96470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of dopaminergic ergot derivatives with cyclic nucleotide system.
    Spano PF; Saiani L; Memo M; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 23():95-102. PubMed ID: 6249093
    [No Abstract]   [Full Text] [Related]  

  • 15. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives.
    Cannon JG; Demopoulos BJ; Long JP; Flynn JR; Sharabi FM
    J Med Chem; 1981 Mar; 24(3):238-40. PubMed ID: 6115056
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).
    Loew DM; Vigouret JM; Jaton A
    Adv Biochem Psychopharmacol; 1980; 23():63-74. PubMed ID: 6104915
    [No Abstract]   [Full Text] [Related]  

  • 18. Ergot alkaloids and phosphodiesterase; 'in vitro' activities in several rat brain areas.
    Venutti P; Ferretti C; Portaleone P
    Experientia; 1982 May; 38(5):601-3. PubMed ID: 6807714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 20. Ergot alkaloids and cyclic nucleotides in the CNS.
    Trabucchi M; Hofmann M; Montefusco O; Spano PF
    Pharmacology; 1978; 16 Suppl 1():150-55. PubMed ID: 205889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.